Axitinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Headache, Nausea, Rash, Breathing difficulty, Joint pain, Difficulty in speaking, Decreased level of thyroid hormones, Pain in extremity, Haemorrhage, Vomiting, Abdominal pain, Dyspepsia, Dry skin, Diarrhoea, Increased blood pressure, Decreased appetite, Cough, Altered taste, Hand-foot syndrome, Constipation, Stomatitis (Inflammation of the mouth), Protein in urine
Axitinib is used in the treatment of kidney cancer.
Yes, Axitinib is approved by FDA.